CIK 0001645113
- Large accelerated filer
NovoCure Ltd
Sign in to watch- Ticker
- NVCR
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Entity type
- Operating
- Phone
- +44 1534756700
- Business address
- NO. 4 THE FORUM, GRENVILLE STREET, ST. HELIER, Jersey
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $142,786
- in 3 filings
Net −$142,786. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-03-08 | Leonard Frank X Chief Development Officer | Sale | −744 | $70.10 | $52K | 102,295 |
| 2022-03-08 | Burke William Patrick Chief Human Resources Officer | Sale | −1,037 | $70.10 | $73K | 55,991 |
| 2022-03-08 | GROENHUYSEN WILHELMUS CM Chief Operating Officer | Sale | −2,923 | $70.10 | $205K | 165,102 |
| 2022-03-08 | Cordova Ashley Chief Financial Officer | Sale | −759 | $70.10 | $53K | 60,848 |
| 2022-03-08 | Longsworth Todd Christopher General Counsel | Sale | −2,339 | $70.10 | $164K | 62,462 |
| 2022-03-08 | DOYLE WILLIAM F Executive Chairman | Sale | −2,385 | $70.10 | $167K | 552,013 |
| 2022-03-07 | Shah Pritesh Chief Commercial Officer | Sale | −5,294 | $69.55 | $368K | 84,389 |
| 2022-03-04 | Longsworth Todd Christopher General Counsel | Sale | −1,973 | $70.41 | $139K | 64,801 |
| 2022-03-04 | Cordova Ashley Chief Financial Officer | Sale | −556 | $70.41 | $39K | 61,607 |
| 2022-03-04 | Shah Pritesh Chief Commercial Officer | Sale | −2,632 | $73.34 | $193K | 91,597 |
| 2022-03-04 | Shah Pritesh Chief Commercial Officer | Sale | −1,914 | $70.41 | $135K | 89,683 |
| 2022-03-04 | Benaim Ely Chief Medical Officer | Sale | −1,510 | $70.41 | $106K | 43,257 |
| 2022-03-04 | Burke William Patrick Chief Human Resources Officer | Sale | −1,026 | $70.41 | $72K | 57,028 |
| 2022-03-04 | GROENHUYSEN WILHELMUS CM Chief Operating Officer | Sale | −2,569 | $70.41 | $181K | 168,025 |
| 2022-03-04 | Leonard Frank X Chief Development Officer | Sale | −555 | $70.41 | $39K | 103,039 |
| 2022-03-03 | Cordova Ashley Chief Financial Officer | Exercise or conversion | +3,840 | $15.60 | $60K | 64,688 |
| 2022-03-03 | Cordova Ashley Chief Financial Officer | Exercise or conversion | +1,200 | $11.46 | $14K | 65,888 |
| 2022-03-03 | Cordova Ashley Chief Financial Officer | Exercise or conversion · Options to Buy Ordinary Shares | −3,840 | $15.60 | $60K | 0 |
| 2022-03-03 | Cordova Ashley Chief Financial Officer | Exercise or conversion · Options to Buy Ordinary Shares | −1,200 | $11.46 | $14K | 7,736 |
| 2022-03-03 | Longsworth Todd Christopher General Counsel | Sale | −1,094 | $74.50 | $82K | 66,774 |
Page 22 of 32 · 638 trades